Long-term safety of ustekinumab in Crohn's disease: Descriptive analysis from an observational post-authorisation safety study using I-CARE cohort data.

Date publication

octobre 2025

Journal

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent

Tous les auteurs :
Peyrin-Biroulet L, Nazar M, Sheahan A, Geldhof A, Azzabi A, Baert F, Mailhat C, Rousseau H, Rahier JF, Beaugerie L

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/41139534

Résumé

Limited data are available from large, prospective cohort studies evaluating the long-term safety of ustekinumab in patients with Crohn's disease.

Mots clés

Infection, Malignancy, Prospective, Venous thromboembolism

Référence

Dig Liver Dis. 2025 10 25;: